MAPS Releases Template to Assist in Federal Drug Sentencing Reform Efforts
27 févr. 2025 15h00 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
In January, the U.S. Sentencing Commission announced proposed amendments to federal drug sentencing guidelines, including lowering the highest base offense level for drug sentences.The proposal also...
MAPS Announces Search for New Executive Director as it Doubles Down on Advocacy and Movement Building
12 févr. 2025 08h30 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion,...
MAPS Launches ‘Music is the Bridge’ Campaign Featuring Lil Yachty, Melissa Etheridge, Reggie Watts and More
09 déc. 2024 09h00 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS’ “Music is the Bridge” blends artist playlists & free psychedelic education, inspiring exploration and connection. Visit MAPS.org/music-is-the-bridge
Psychedelic Science 2025 Conference Announces Workshops, Holiday Sale, and Scholarship Deadline
05 déc. 2024 15h44 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
World’s leading psychedelic conference kicks off with workshops from leaders in science, medicine, therapy, policy, Indigenous medicine, and societyUpcoming deadline: speaker submissions, initial...
MAPS Successfully Clears Path for Cannabis Research through FDA Formal Dispute
20 nov. 2024 12h40 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
After three years of negotiation with the FDA, MAPS has successfully secured FDA clearance to conduct a clinical trial, MJP2, to examine the use of smoked cannabis for the treatment of PTSD symptoms...
MAPS Awards Grant for Pilot MDMA-assisted Massed Exposure Therapy Trial
27 août 2024 07h00 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS, which has incubated and funded cutting-edge psychedelic research for decades, is continuing to advance our understanding of psychedelic-assisted therapiesThis study is one of the first trials...
MAPS Statement on FDA Complete Response Letter for MDMA-Assisted Therapy for PTSD New Drug Application
09 août 2024 21h33 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS remains confident in its goal of making access to MDMA-assisted therapy for PTSD safe and legal SAN JOSE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for...
Three Pivotal Drug Policy Organizations Hold Media Briefing/Q&A on DEA Rescheduling of Cannabis
01 mai 2024 17h54 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
WASHINGTON, May 01, 2024 (GLOBE NEWSWIRE) -- What: The Multidisciplinary Association for Psychedelic Studies (MAPS), The Marijuana Policy Project (MPP), and the National Organization for the...
MAPS Provides Psychedelic Crisis Assessment and Intervention Training to Denver’s First Responders
11 mars 2024 11h50 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS uses its over 30 years of experience in the psychedelic space to offer a first-of-its-kind gold-standard training program.
MAPS Announces Celestial Plans for Its 38th Anniversary
07 mars 2024 12h34 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS, which celebrates its 38th anniversary on April 8, will celebrate with a total solar eclipse at the Texas Eclipse 2024 festival in Texas